Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England Jonathan ValabhjiNaomi HolmanKetan Dhatariya Article Open access 08 April 2024 Pages: 1304 - 1314
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database Aikaterini EleftheriadouDavid RileyUazman Alam Article Open access 08 April 2024 Pages: 1271 - 1282
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology Aleksey MatveyenkoAdrian Vella Letter 06 April 2024 Pages: 1444 - 1445
Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy Eva Sierra‑SilvestreRicardo J. AndradeMichel W. Coppieters Correction Open access 05 April 2024 Pages: 1450 - 1450
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter] Nikhil R. GandasiPatrik Rorsman Letter 05 April 2024 Pages: 1446 - 1447
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring Yaxin WangSiwan LiJian Zhou Article Open access 03 April 2024 Pages: 1295 - 1303
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study Cong XiePeter IrogaTongzhi Wu Article Open access 01 April 2024 Pages: 1260 - 1270
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial Ditte S. KornumDavide BertoliAsbjørn M. Drewes Article Open access 28 March 2024 Pages: 1122 - 1137
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial Elske L. van den BurgMarjolein P. SchoonakkerHanno Pijl Article Open access 28 March 2024 Pages: 1245 - 1259
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults M. Loredana MarcovecchioA. Emile J. Hendrikson behalf of the INNODIA consortium Article Open access 22 March 2024 Pages: 995 - 1008
Effectiveness and safety of empagliflozin: final results from the EMPRISE study Phyo T. HtooHelen TesfayeElisabetta Patorno Article 21 March 2024 Pages: 1328 - 1342
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity Vanessa YuFiona YongSteven J. Millership Article Open access 21 March 2024 Pages: 1079 - 1094
CK2 activity is crucial for proper glucagon expression Emmanuel AmpofoMandy PackClaudia Götz Extended Article Open access 20 March 2024 Pages: 1368 - 1385
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts Nicolai A. Lund-BlixAnne A. BjerregaardLars C. Stene Short Communication Open access 19 March 2024 Pages: 1023 - 1028
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort Lauren V. TurnerMartin Chase Marakfor the T1DEXI Study Group Article 19 March 2024 Pages: 1009 - 1022
Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes Dakota GustafsonPeter V. DiStefanoJason E. Fish Article Open access 15 March 2024 Pages: 1138 - 1154
A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial Alistair J. MonteyneKaja FalkenhainJonathan P. Little Short Communication Open access 14 March 2024 Pages: 1107 - 1113
Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium Matthew N. AhmadiJoanna M. BlodgettEmmanuel Stamatakis Article Open access 13 March 2024 Pages: 1051 - 1065
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study Franziska G. RauscherTobias ElzeMengyu Wang Article Open access 02 March 2024 Pages: 928 - 939
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter] Merel M. RuissenEwout W. SteyerbergJacob K. Sont Letter 01 March 2024 Pages: 956 - 957
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention Frans PouwerSonya Deschênes Letter 01 March 2024 Pages: 954 - 955
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals Rui SheTommi SuvitaivalUlrik Pedersen-Bjergaard Article Open access 01 March 2024 Pages: 1095 - 1106
Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study Sirimon ReutrakulJason C. ParkErin C. Hanlon Short Communication 27 February 2024 Pages: 1114 - 1121
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment Mengqi SuYilin HouCong Chen Article Open access 27 February 2024 Pages: 850 - 863
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank Qiao JinEric S. H. Lauon behalf of the Hong Kong Diabetes Biobank Study Group Article Open access 27 February 2024 Pages: 837 - 849
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Rosa M. Sánchez-HernándezAna M. Wägner Letter 26 February 2024 Pages: 952 - 953
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes Alexandra Coomans de BrachèneMaria Ines AlvelosDecio L. Eizirik Extended Article 26 February 2024 Pages: 908 - 927
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people Carolin T. LehnerMarian EberlStefanie J. Klug Article Open access 26 February 2024 Pages: 1040 - 1050
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study Jonne G. ter BraakeKelly J. Fleetwoodon behalf of the Scottish Diabetes Research Network Epidemiology Group Article Open access 26 February 2024 Pages: 1029 - 1039
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research Jeremy Basset‑SagarminagaTineke van de WeijerVera Schrauwen‑Hinderling Correction 23 February 2024 Pages: 958 - 958
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study Jimmy CélindMaria BygdellJenny M. Kindblom Article Open access 22 February 2024 Pages: 874 - 884
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Pedro CardosoKatie G. Youngon behalf of the MASTERMIND consortium Article Open access 22 February 2024 Pages: 822 - 836
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment Richard I. G. HoltClive S. CockramAndrea O. Y. Luk Review Open access 20 February 2024 Pages: 1168 - 1180
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Sophie BéliardFlorian MourreRené Valéro Review Open access 20 February 2024 Pages: 974 - 984
Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits Jianxin ZhenYuqin GuSiyang Liu Article Open access 19 February 2024 Pages: 703 - 713
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study Roderick C. SliekerMagnus MünchJoline W. J. Beulens Article Open access 19 February 2024 Pages: 885 - 894
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial Heikki HyötySusanna KääriäinenMiguel Sanjuan Article Open access 19 February 2024 Pages: 811 - 821
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life Natascia VedovatoMaria V. SalgueroFrances M. Ashcroft Article Open access 17 February 2024 Pages: 940 - 951
Metabolomic and genetic architecture of gestational diabetes subtypes Kristen LeeAlan KuangWilliam L. Lowe Jr Article 17 February 2024 Pages: 895 - 907
The insulin resistant brain: impact on whole-body metabolism and body fat distribution Martin Heni Review Open access 16 February 2024 Pages: 1181 - 1191
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis Milena JancevTessa A. C. M. VissersThomas T. van Sloten Article Open access 16 February 2024 Pages: 798 - 810
Feasibility of prevention of type 2 diabetes in low- and middle-income countries Andre P. KengneAmbady Ramachandran Review Open access 15 February 2024 Pages: 763 - 772
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data Pedro F. TeixeiraTadej BattelinoGun Forsander For Debate Open access 14 February 2024 Pages: 985 - 994
Keeping pace: the primary cilium as the conducting baton of the islet Olof Idevall-HagrenCeren Incedal NilssonGonzalo Sanchez Review Open access 14 February 2024 Pages: 773 - 782
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial Matthias BlüherJulio RosenstockAnita M. Hennige Correction Open access 13 February 2024 Pages: 758 - 758
A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes Mengqi GuoHan GuoShufa Li Article 13 February 2024 Pages: 623 - 640
Harnessing the power of proteomics in precision diabetes medicine Nigel KurganJeppe Kjærgaard LarsenAtul S. Deshmukh Review 12 February 2024 Pages: 783 - 797
